![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2366 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Tabernero, Josep (Vall d’Hebron Institute of Oncology 201506 Director) | President/Director/Head of Research Organisation/Unit | Vall d’Hebron Institute of Oncology (VHIO) | Catalonia |
| Tabouis, Stéphanie (Publicis 201411) | Public Relations Manager / Investor Relations Manager | Publicis (Group) | Île-de-France (region) |
| Tai, Pasteur K. (Cold Spring Biotech 202204 President) | President/Director/Head Business Group/Unit/Division | Cold Spring Biotech Corporation | Beijing (Peking) (province) |
| Takacs, Laszlo (BioSystems International 200512 CEO) | Chief Executive Officer (CEO) | BioSystems International (Group) | France (region/state unspecified) |
| Talbot, Jonathan (Mosanna Therapeutics 202207 CEO + Co-Founder) | Chief Executive Officer (CEO) | Mosanna Therapeutics AG | Northwestern Switzerland (region) |
| Tallec, Clément (eureKARE 202208 CFO) | Chief Financial Officer (CFO) | eureKARE (Group) | Luxembourg (cl=4) |
| Tambourin, Pierre (Genopole 1998– Chief Executive) | Chief Executive Officer (CEO) | Genopole (GIP Genopole) | Île-de-France (region) |
| Tambuyzer, Erik (Augustine Therapeutics 202103– Board Director representing PMV formerly Genzyme Europe + Innogenetics) | Board member, non-executive | Augustine Therapeutics (BE) | Flanders (Flemish region) |
| Tanda, Stephan B. (Aptar 202106 CEO before DSM 201508 Executive Board Member Life Sciences) | Chief Executive Officer (CEO) | Aptar (Group) | Illinois (federal state) |
| Tangy, Frederic (Institut Pasteur 201907 Director of Viral Genomics + Vaccination Unit + Founder of Oncovita SAS) | Researcher (university / research institute) | Institut Pasteur | Île-de-France (region) |
| Taub, Robert (Nyxoah 20009– CEO + Co-Founder formerly Omrix –200802– CEO) | Chief Executive Officer (CEO) | Nyxoah S.A. | Belgium_o |
| Tauber, Erich (Themis Bioscience GmbH 201505 CEO) | Chief Executive Officer (CEO) | Merck (US) (MSD) (Group) | Wien (state) |
| Tavares, Maria da Graça (Eric Salmon & Partners 201410) | Human Resources Manager | Eric Salmon & Partners (Group) | Hessen (Hesse) (federal state) |
| Tavazoie, Masoud (Rgenix 201810 CEO + Co-Founder) | Chief Executive Officer (CEO) | Inspirna Inc. | New York (federal state) |
| Taverne, Cindy (Yucatan RP 201511) | Public Relations Manager / Investor Relations Manager | Yucatan S.a.r.l. (agence RP) | Île-de-France (region) |
| Tchelingerian, John (Promethera 201509– CEO before Silver Ocean Ventures + Neurotech + Diatos) | Chief Executive Officer (CEO) | Promethera (Group) | Belgium_o |
| Tellier, Jean-Christophe (UCB 201403– CEO-elect joined UCB 2011 before Ipsen + Macrogenics + Novartis) | Chief Executive Officer (CEO) | UCB (Group) | Brussels (region) |
| Tempelaere, Vincent (Eveon 202301 CEO) | Chief Executive Officer (CEO) | Eveon SAS | France (region/state unspecified) |
| Templier, Alexandre (Quinten 202209 CEO + Co-Founder of Quinten) | Chief Executive Officer (CEO) | Quinten (Group) | Île-de-France (region) |
| Tenkanen, Tuomas (Mobidiag 201304– CEO before RnD Director of Diagnostics PCR at Finnzymes) | Chief Executive Officer (CEO) | Hologic (Group) | Uusimaa |
| Teper, Daniel (Cytovia Therapeutics 202102 CEO + Co-Founder) | Chief Executive Officer (CEO) | Cytovia Therapeutics Inc. | Massachusetts (federal state) |
| Termeer, Henri A. (Genzyme 1985–201106 CEO joined Genzyme 1983) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | Massachusetts (federal state) |
| Thaker, Sumi (Momentum Bioscience 2016– CEO before Thermo Fisher + bioMérieux) | Chief Executive Officer (CEO) | Momentum Bioscience Ltd. | Wales |
| Tharaud, Cécile (INSERM 201403– CEO of Inserm Transfert Initiative before CEO of Inserm Transfert) | Chief Executive Officer (CEO) | France (govt) | Île-de-France (region) |
| Thébault, Cécile (Sofimac Partners 201411 Investment Director) | Investment Manager | Sofimac Partners (FR) | Auvergne-Rhône-Alpes (region) |
| Theodosiou, Jason (Aureus Pharma 200612– CEO before COO before Elsevier MDL + Lion Bioscience) | Chief Executive Officer (CEO) | Reed Elsevier (Group) | Île-de-France (region) |
| Thérasse, Patrick (Servier 201703 Director of Clinical Development Oncology) | Clinical Research Manager | Servier (Group) | Île-de-France (region) |
| Therin, Michel (Affluent Medical 202401 Board Chair) | Board member, non-executive | Affluent Medical (Group) | Provence-Alpes-Côte d’Azur (region) |
| Therme, Jean (CEA 200912 Director of Technological Research) | n. a. | CEA (Group) | Île-de-France (region) |
| Theurillat, Jacques (Ares Life Sciences CEO before Serono) | Chief Executive Officer (CEO) | BERTARELLI Group (family of Ernesto Bertarelli) | Région Lémanique (region) |
| Thiam, Kader (genOway 201809 VP Transgenic Technologies) | n. a. | genOway (Group) | Auvergne-Rhône-Alpes (region) |
| Thiedey, Benoit (Alto Invest 201703 Investment Manager) | Investment Manager | Alto Invest (FR) | Île-de-France (region) |
| Thiel, Thorsten (Bruker 201204 Director Marketing Communications) | Public Relations Manager / Investor Relations Manager | Bruker (Group) | Baden-Württemberg (federal state) |
| Thielgen, Detlef (UCB 2007–2020H1 CFO) | Chief Financial Officer (CFO) | UCB (Group) | Brussels (region) |
| Thiney, Pierre-Louis (Mérieux 201307 Executive Director US Industry at bioMérieux) | President/Director/Head Business Group/Unit/Division | Mérieux (Group) | North Carolina (federal state) |
| Thiroloix, Stéphane (AlgoTherapeutix 202303 CEO + Founder formerly Mayoly Spindler + Eucomed + Smith & Nephew + Ipsen) | Chief Executive Officer (CEO) | AlgoTherapeutix SAS (AlgoTx) | Île-de-France (region) |
| Thiry, Christian (Novasep 201308–201703 CFO before 12 years Stallergenes CFO GING 3/17) | Chief Financial Officer (CFO) | Novasep (Group) | Grand Est (Great East) (region) |
| This Saint-Jean, Isabelle (Genopole 201409– President) | President/Director/Head Business Group/Unit/Division | Genopole (GIP Genopole) | Île-de-France (region) |
| Thistle, Mary (Enterome 201707– Non-Executive Board Director main org Dimension Therapeutics before Cubist Pharma) | Chief Operating Officer (COO) | Ultragenyx (Group) | Massachusetts (federal state) |
| Thoma, Heidrun (Boehringer 201109 Media + Public Relations) | Public Relations Manager / Investor Relations Manager | Boehringer Ingelheim (Group) | Rheinland-Pfalz (federal state) |
| Thomas, Kirsten (Ruth Group 201610) | Public Relations Manager / Investor Relations Manager | Ruth Group, The (TRG) | New York (federal state) |
| Thompson, Kristin (eureKARE 202208 CBO before Bioaster + Famar + DaVolterra) | Chief Business Officer (CBO) | eureKARE (Group) | Luxembourg (cl=4) |
| Thomson, Linden (New York Life 202402– Senior Fund Manager, Thematic Global Equity, Biotech at Candriam before AXA) | Investment Manager | New York Life (Group) | Luxembourg (cl=4) |
| Thornback, John (Myconostica 200804 COO) | Chief Operating Officer (COO) | Novacyt (Group) | North West England (region) |
| Thys, Hendrik (Ziphius Vaccines 202105 IR Manager formerly Consilium Strategic Communications 201602) | Public Relations Manager / Investor Relations Manager | Ziphius Vaccines N.V. | Flanders (Flemish region) |
| Tiennot-Herment, Laurence (Généthon 201509 President) | President/Director/Head Business Group/Unit/Division | French Myopathy Association (AFM) | Île-de-France (region) |
| Tierny, Dominique (OCR (FR) 201901 CEO + Founder) | Chief Executive Officer (CEO) | OCR (Oncovet Clinical Research) (FR) | Hauts-de-France (Upper France) (region) |
| Tillier, Bruno (Synthelis 201101– President + Co-Founder) | President/Director/Head Business Group/Unit/Division | Synthelis (FR) | Auvergne-Rhône-Alpes (region) |
| Timmerman, Benedikt (Genticel 201304 CEO + Founder) | Chief Executive Officer (CEO) | Calliditas Therapeutics (Group) | Occitanie (Occitania) (region) |
| Tirouflet, Jean-Pierre (Biosystems International 200810 CEO) | Chief Executive Officer (CEO) | BioSystems International (Group) | France (region/state unspecified) |
| Tobelem, Gérard (Theradiag 201404 Chairman) | Board member | Theradiag (Group) | Île-de-France (region) |
| Tocqué, Bruno (ExonHit 200506 CEO) | Chief Executive Officer (CEO) | Eurobio Scientific (Group) | Île-de-France (region) |
| Todosiev, Geoff (Interchim 201402 President of Interchim Inc) | President/Director/Head Business Group/Unit/Division | Interchim (Group) | California (federal state) |
| Tokay, Alexandre (Vect-Horus 201506 CEO + Co-founder) | Chief Executive Officer (CEO) | Vect-Horus (FR) | Provence-Alpes-Côte d’Azur (region) |
| Tolmachov, Andrey (Enamine 202203 CEO + Founder) | Chief Executive Officer (CEO) | Enamine Ltd. (UA) | Ukraine_o |
| Tongio, Isabelle (Mérieux 201107 Investor Relations at bioMérieux) | public relations / investor relations | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Tordjman, Rafaèle (Jeito Capital 201806– President + Founder before Sofinnova Partners 2001–2017) | Managing Partner (investment firm) | Jeito Capital (Group) | Île-de-France (region) |
| Tortet, Ivan (GenSight Biologics 202402 CFO) | Chief Financial Officer (CFO) | GenSight Biologics S.A. (Euronext: SIGHT) | Île-de-France (region) |
| Touchon, Pascal (Atara Biotherapeutics 201906– CEO before Novartis +Servier) | Business Development Manager / Strategy Manager | Atara Biotherapeutics (Group) | California (federal state) |
| Toulemonde, Caroline (Inova Software 202201 Chief Strategy Officer) | Corporate Strategy Manager | Inpart (Group) | Auvergne-Rhône-Alpes (region) |
| Toulemonde, Gilles (Inova Software 201809 CEO + Co-Founder) | Chief Executive Officer (CEO) | Inpart (Group) | Auvergne-Rhône-Alpes (region) |
| Tounetki, Naceur (Genopole 201207– Deputy Director joined 200404 before Genset) | President/Director/Head Business Group/Unit/Division | Genopole (GIP Genopole) | Île-de-France (region) |
| Tourniaire, Guilhem (Scienion 201610 Managing + Scientific Director of Cellenion SASU) | Managing Director | Bico (Group) | Auvergne-Rhône-Alpes (region) |
| Tousi, Susan (Delfi Diagnostics 202401– CEO before Illumina + Eastman Kodak + HP) | Chief Executive Officer (CEO) | Delfi Diagnostics Inc. | Maryland (federal state) |
| Touya, Gael (Aptar 202106 President of Aptar Pharma) | President/Director/Head Business Group/Unit/Division | Aptar (Group) | Illinois (federal state) |
| Toyne-Sewell, Melanie (Instinctif Partners 201509) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | Greater London (region) |
| Tramoy, Philippe (Seventure Partners 201504 Investment Director at Quadrivium 1 seed fund) | Chief Executive Officer (CEO) | BPCE (Group) | Île-de-France (region) |
| Tran, Quang (Stilla Technologies 201911– Director Quality + Regulatory Affairs before BioSerenity + BD + Eurobio) | Regulatory Affairs Manager | Stilla Technologies (Group) | Île-de-France (region) |
| Tregoning, Kathleen (Sanofi 201702– EVP External Affairs before Biogen) | Public Relations Manager / Investor Relations Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Treillou, Jean-Luc (LNC Therapeutics 201807– Chairman before CEO) | Board member, non-executive | LNC Therapeutics (FR) | Nouvelle-Acquitaine (New Acquitaine) (region) |
| Trenkle, Jim (Sanofi 202106 US Head of Investments at Sanofi Ventures) | Investment Manager | Sanofi (Group) [since May 2011] | Massachusetts (federal state) |
| Triomphe, Thomas (Sanofi 202112 EVP Global Head of Sanofi Pasteur) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | |
| Tripathi, Vineeta (Vitarka Therapeutics 2021– CEO + Founder before Boehringer Ingelheim + Ipsen Bioinnovation) | Chief Executive Officer (CEO) | Vitarka Therapeutics Ltd. | South East England (region) |
| Tripodi, Federico A. (Cellectis 201609c– CEO of Calyxt before Monsanto) | Chief Executive Officer (CEO) | Cellectis (Group) | Minnesota (federal state) |
| Triva, Stefania (Copan 201501 CEO + General Manager) | Chief Executive Officer (CEO) | Copan (Group) | Lombardia (Lombardy) |
| Trombe, Emmanuelle (McDermott Will & Emery 201701 Partner in Life Sciences Group in Paris) | Attorney / Lawyer | McDermott Will & Emery (MWE) (Group) | Île-de-France (region) |
| Tuffet, Sophie (Imagene 201907 CEO) | Chief Executive Officer (CEO) | Imagene S.A. | Nouvelle-Acquitaine (New Acquitaine) (region) |
| Tupin, Cyrille (Abionyx 201909– CEO before Deputy CEO + CFO of predecessor Cerenis Therapeutics) | Chief Executive Officer (CEO) | Abionyx (Group) | Occitanie (Occitania) (region) |
| Tupinon-Mathieu, Isabelle (Servier 201411 Head of Metabolism Innovative Center) | Research & Development Manager | Servier (Group) | Île-de-France (region) |
| Turenne, G. Andre (Matchpoint Therapeutics 202210 CEO before Voyager Tx + Sanofi + Genzyme + Feinstein Kean Healthcare) | Chief Executive Officer (CEO) | Matchpoint Therapeutics Inc. | Massachusetts (federal state) |
| Turner, Simon (Sofinnova 202303 Partner at Sofinnova Partners) | Partner (venture partner) | Sofinnova (Group) | Île-de-France (region) |
| Turner, Stephen (Steve) (Protea Biosciences 201002 CEO) | Chief Executive Officer (CEO) | Protea Biosciences (Group) | West Virginia (federal state) |
| Törnsén, Maria (Passage Bio 202107– Chief Commercial Officer before Sarepta Therapeutics + Sanofi Genzyme + Shire) | Chief Commercial Officer (CCO) | Passage Bio Inc. (PASG) | Pennsylvania (federal state) |
| Ubags, Frank (Cevec 201504– CEO before COO since 201409 before Coral BioNet + Scil Proteins + Kiadis + Rhein Biotech) | Chief Operating Officer (COO) | Danaher (Group) | Nordrhein-Westfalen (federal state) |
| Uhrich, Christian (Merck (DE) 202306 Principal at M Ventures) | Principal (venture capital) | Merck (DE) (Group) | North Holland (province, NL) |
| Ulmann, André (Advicenne 202102– CMO before interim CEO) | Chief Executive Officer (CEO) | Advicenne S.A. (Euronext Paris: ADVIC) | Occitanie (Occitania) (region) |
| Ulrich, Peter G. (TargeGen 201006 CEO + Co-founder) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | California (federal state) |
| Unkelbach, Gerd (Fraunhofer 201311 Head of CBP in Leuna) | n. a. | Fraunhofer (Group) | Sachsen (federal state) |
| Unterrainer, Gertraud (ProBioGen 200710– CFO before Biovertis) | Chief Financial Officer (CFO) | Minapharm (Group) | Berlin (federal state) |
| Usache, Vincent (Microphyt 201907 CEO) | Chief Executive Officer (CEO) | Microphyt S.A. | Occitanie (Occitania) (region) |
| Userovici, Jonathan (Eurazeo 202001 Investment Manager at Idinvest Partners) | Investment Manager | Eurazeo (Group) | Île-de-France (region) |
| Vadsholt, Anders (TopoTarget 201011 CFO) | Chief Financial Officer (CFO) | Onxeo (Group) | Hovedstaden |
| Vaeck, Mark (Complix 201005– CEO before co-founder + founding CEO of ActoGenix + before Ablynx CEO) | Chief Executive Officer (CEO) | Complix (Group) | Flanders (Flemish region) |
| Vaillant, Renaud (Theravectys 201209 CEO + France Biotech 201508 Board Director) | Chief Executive Officer (CEO) | Theravectys S.A. | Île-de-France (region) |
| Valachs, Philippe (Cellectis 201110– General Secretary) | management (personnel) | Cellectis (Group) | Île-de-France (region) |
| Valencony, François (Mérieux 201601 General Manager of Mérieux Developpement) | General Manager (management) | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Valla, Sophie (Keranova 201604 before Bausch and Lomb / Valeant) | n. a. | Keranova S.A. | France (region/state unspecified) |
| Valle, Francois (Vaxon Biotech 201412 CEO + MabLife 2014 CEO before Genewave) | Chief Executive Officer (CEO) | Vaxon Biotech S.A. | Île-de-France (region) |
| Van Acker, Bart (Quality by Design 202204 CEO + Founder) | Chief Executive Officer (CEO) | QbD Group (Quality by Design) (Group) | Flanders (Flemish region) |
| Van Beneden, Patrick (GIMV 201306) | Investment Manager | Gimv (Group) | Belgium_o |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
